REGenableMED

PI: Andrew Webster, University of York, Science and Technology Studies Unit (SATSU)

(2014-2017)

“REGenableMED is an ESRC-funded project examining the dynamics of innovation within the field of regenerative medicine. Using a mixed-methods social science approach, the project undertakes a detailed analysis of the interplay between business models, measures of clinical utility, patterns of regulatory oversight and clinical workflows within healthcare settings. The results of the research will inform strategies aimed at facilitating the responsible development of effective and useful regenerative medicine products and services“. 

Tiss.EU

PI: Christian Lenk, Universität Göttingen, Stiftung Öffentlichen Rechts

(2008-2011)

The acronym Tiss.EU stands for „Evaluation of Legislation and Related Guidelines on the Procurement, Storage and Transfer of Human Tissues and Cells in the European Union – an Evidence-Based Impact Analysis. The project analyses the impact of current EU legislation and guidelines on biomedical research which is based on the procurement, storage and transfer of human tissues and cells in and across the European Union. 

EUCelLEX

PI: Emmanuelle Rial-Sebbag, CERPOP, UMR 1295, Inserm, Université de Toulouse – Université Paul Sabatier -Toulouse III

(2013-2016)

“The EUcelLEX project was aiming at collecting and analysing facts and figures in order to assess the current legislation on the therapeutic use of somatic cells, and to bridge it with the research infrastructure capacity building“.